p53 autoantibodies predict subsequent development of cancer
about
Serum growth factors in asbestosis patientsEmerging blood-based biomarkers for detection of gastric cancerDevelopment and validation of a high throughput system for discovery of antigens for autoantibody detectionSplit T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors.Clinical validation of an autoantibody test for lung cancer.Serum p53 antibody detection in patients with impaired lung function.Comparison of candidate serologic markers for type I and type II ovarian cancerDiagnostic potential of zinc finger protein-specific autoantibodies and associated linear B-cell epitopes in colorectal cancer.Analysis of the expression of human tumor antigens in ovarian cancer tissuesEarly detection of cancer in the general population: a blinded case-control study of p53 autoantibodies in colorectal cancer.Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer.The clinical significance of autoantibodies in gastrointestinal malignancies: an overview.Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancerOncogene and tumor-suppressor gene products as serum biomarkers in occupational-derived lung cancer.Serum anti-CCNY autoantibody is an independent prognosis indicator for postoperative patients with early-stage nonsmall-cell lung carcinomaEvaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer serap53 autoantibodies, cytokine levels and ovarian carcinogenesisTumor autoantibodies as biomarkers for predicting ovarian cancer recurrence.Prevalence of antitumor antibodies in laying hen model of human ovarian cancerAutoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinomaIdentifying autoantibody signatures in cancer: a promising challenge.Panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer.Lung cancer - can autoantibodies provide an aid to diagnosis?Autoantibodies response to MDM2 and p53 in the immunodiagnosis of esophageal squamous cell carcinoma.Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer.Early detection of lung cancer by using an autoantibody panel in Chinese population.Gold-loaded nanoporous iron oxide nanocubes: a novel dispersible capture agent for tumor-associated autoantibody analysis in serum.[Autoantibodies as the early diagnostic biomarkers for lung cancer].Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancer
P2860
Q23924074-2331250A-64D0-4004-B141-CA51D8F1A6D2Q26778026-A73B45EC-ED65-4917-9C6E-FFF8BD700CCCQ28729058-7B2E4D74-AA26-4C24-8EF0-55E8BD9721D5Q33999909-67026166-E89E-44A9-A01A-E95C963B24F6Q34537374-AF720305-9898-4FA3-AB5D-45917E4D9E42Q34577526-D9AC3163-DAF6-4561-9DE4-ED4059D12EC2Q35154077-CD810826-1821-43FE-A4EA-3F554C1AACA0Q35394661-0D52CAF3-8086-415D-A550-62A6E5DB605EQ35930779-16FE4179-04FA-43B6-AC2C-F6D58E62DD6CQ36557829-01989AEF-7565-4348-8752-87FB9EE869A2Q36709561-4EEA300E-22D5-4A31-B8C9-B71F372C3222Q36764924-D8661256-F462-48C2-9807-201638985AF9Q36896106-56A88D73-F7BB-4539-A0D0-04A25B1E6F02Q36950436-CB155D41-09D3-4712-8A9C-24E48A83E5A7Q37212230-BF147EDC-0484-4E02-A11E-79541197CC5AQ37215382-8CDAABB2-2C27-441F-BC47-89452D8B3620Q37223836-7BEEFC64-124C-4F0E-9771-BD9345E306F9Q37285033-5CA8D51A-1FEF-48F3-92D4-8DE55C963635Q37436255-AC7D307B-E94C-4C1C-8D50-FE0FBD0355B9Q37460909-26FAE33E-3571-415B-BFD0-81A98F1C6A3BQ37579900-9C52DC95-0C1B-47DB-8F74-C6C8F0EC4304Q37735594-91FB52AD-6546-4AA9-A75F-9DE5F131F6EFQ38089785-2AC59569-3FCB-4081-B47C-A00ACD48DECCQ38981242-40832BAB-E7CE-4927-9D44-8694A38496F6Q40428099-66ECF794-8E0F-4AFD-BE2E-C90C9A2B5890Q47664013-9D494AB0-ABBC-45EA-AB1F-664CCCDE4CEAQ48753963-F50D3349-0563-4B9F-8815-97EB92DEE282Q55436520-BE6A2374-0CF9-4D01-8FA5-C994E4D1B000Q57694335-9E1C86D0-7FE1-4FEC-B4D1-B67BF5FA703B
P2860
p53 autoantibodies predict subsequent development of cancer
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
p53 autoantibodies predict subsequent development of cancer
@ast
p53 autoantibodies predict subsequent development of cancer
@en
p53 autoantibodies predict subsequent development of cancer
@en-gb
p53 autoantibodies predict subsequent development of cancer
@nl
type
label
p53 autoantibodies predict subsequent development of cancer
@ast
p53 autoantibodies predict subsequent development of cancer
@en
p53 autoantibodies predict subsequent development of cancer
@en-gb
p53 autoantibodies predict subsequent development of cancer
@nl
prefLabel
p53 autoantibodies predict subsequent development of cancer
@ast
p53 autoantibodies predict subsequent development of cancer
@en
p53 autoantibodies predict subsequent development of cancer
@en-gb
p53 autoantibodies predict subsequent development of cancer
@nl
P2093
P921
P356
P1476
p53 autoantibodies predict subsequent development of cancer
@en
P2093
Antti Karjalainen
Harri Vainio
Heikki Koskinen
Michael Shnaidman
Paul W. Brandt-Rauf
Yongliang Li
Zhiliang Ying
P2880
P304
P356
10.1002/IJC.20715
P577
2005-03-10T00:00:00Z